NASDAQ:ATHA

Athira Pharma, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$2.04

+0.0700 (+3.55%)

At Close: May 01, 2024

Currently predicting for Fri, 3 May 2024

Trading levels for ATHA

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.09	2.29 %
		R2	2.06	1.16 %
		R1	2.05	0.470 %
Current price:			2.04
	Support	S1	2.00	-1.78 %
		S2	1.99	-2.47 %
		S3	1.97	-3.59 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	2.52	23.53 %
		R2	2.46	20.34 %
		R1	2.24	9.80 %
Current price			2.04
	Support	S1	2.01	-1.47%
		S2	1.97	-3.43%
		S3	1.92	-5.88%

ATHA Predictions History

2 years ago
JS predicted that ATHA for 2021-06-22 is going $11.06 (6.96%)

2 years ago
JS predicted that ATHA for 2021-06-21 is going $12.37 (15.07%)

About Athira Pharma, Inc.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkins... ATHA Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In